NUMD (Nu-Med Plus) Current Accrued Expense: $0.02 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Nu-Med Plus Current Accrued Expense?

Nu-Med Plus NUMD Current Accrued Expense is $0.02 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Nu-Med Plus's Current Accrued Expense for the quarter that ended in Mar. 2026 was $0.02 Mil.

Nu-Med Plus's quarterly Current Accrued Expense increased from Sep. 2025 ($0.02 Mil) to Dec. 2025 ($0.02 Mil) and increased from Dec. 2025 ($0.02 Mil) to Mar. 2026 ($0.02 Mil).

Nu-Med Plus's annual Current Accrued Expense increased from Dec. 2023 ($0.01 Mil) to Dec. 2024 ($0.01 Mil) and increased from Dec. 2024 ($0.01 Mil) to Dec. 2025 ($0.02 Mil).

Nu-Med Plus Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Nu-Med Plus's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nu-Med Plus Current Accrued Expense Chart

Nu-Med Plus Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.00 0.01 0.01 0.02

Nu-Med Plus Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.02 0.02 0.02

Nu-Med Plus Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.02 Mil mean?
Nu-Med Plus (NUMD) has a Current Accrued Expense of $0.02 Mil as of Mar. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Nu-Med Plus and its competitors.
Is Nu-Med Plus' Current Accrued Expense too high?
Nu-Med Plus' current Current Accrued Expense is $0.02 Mil.
How does Nu-Med Plus' Current Accrued Expense compare to AEMD and AMIX?
Nu-Med Plus' Current Accrued Expense of $0.02 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Nu-Med Plus and its competitors. Nu-Med Plus's current Current Accrued Expense is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nu-Med Plus stock overvalued right now?
Nu-Med Plus (NUMD) has a current Current Accrued Expense of $0.02 Mil. The current Current Accrued Expense is $0.02 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Nu-Med Plus (NUMD), the current Current Accrued Expense is $0.02 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nu-Med Plus Business Description

Address 640 Belle Terre Road, Building 2 E Port, Jefferson, NY, USA, 11777
Nu-Med Plus Inc is a medical device company engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems, and the medical community throughout the world. It is currently working to locate a merger partner that will be able to fund the final development of these products.